422 related articles for article (PubMed ID: 33095853)
1. Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study.
Geretti AM; Stockdale AJ; Kelly SH; Cevik M; Collins S; Waters L; Villa G; Docherty A; Harrison EM; Turtle L; Openshaw PJM; Baillie JK; Sabin CA; Semple MG
Clin Infect Dis; 2021 Oct; 73(7):e2095-e2106. PubMed ID: 33095853
[TBL] [Abstract][Full Text] [Related]
2. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.
Bloom CI; Drake TM; Docherty AB; Lipworth BJ; Johnston SL; Nguyen-Van-Tam JS; Carson G; Dunning J; Harrison EM; Baillie JK; Semple MG; Cullinan P; Openshaw PJM;
Lancet Respir Med; 2021 Jul; 9(7):699-711. PubMed ID: 33676593
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score.
Knight SR; Ho A; Pius R; Buchan I; Carson G; Drake TM; Dunning J; Fairfield CJ; Gamble C; Green CA; Gupta R; Halpin S; Hardwick HE; Holden KA; Horby PW; Jackson C; Mclean KA; Merson L; Nguyen-Van-Tam JS; Norman L; Noursadeghi M; Olliaro PL; Pritchard MG; Russell CD; Shaw CA; Sheikh A; Solomon T; Sudlow C; Swann OV; Turtle LC; Openshaw PJ; Baillie JK; Semple MG; Docherty AB; Harrison EM;
BMJ; 2020 Sep; 370():m3339. PubMed ID: 32907855
[TBL] [Abstract][Full Text] [Related]
4. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.
Russell CD; Fairfield CJ; Drake TM; Turtle L; Seaton RA; Wootton DG; Sigfrid L; Harrison EM; Docherty AB; de Silva TI; Egan C; Pius R; Hardwick HE; Merson L; Girvan M; Dunning J; Nguyen-Van-Tam JS; Openshaw PJM; Baillie JK; Semple MG; Ho A;
Lancet Microbe; 2021 Aug; 2(8):e354-e365. PubMed ID: 34100002
[TBL] [Abstract][Full Text] [Related]
5. Changes in hospital mortality in patients with cancer during the COVID-19 pandemic (ISARIC-CCP-UK): a prospective, multicentre cohort study.
Turtle L; Elliot S; Drake TM; Thorpe M; Khoury EG; Greenhalf W; Hardwick HE; Leeming G; Law A; Oosthuyzen W; Pius R; Shaw CA; Baillie JK; Openshaw PJM; Docherty AB; Semple MG; Harrison EM; Palmieri C;
Lancet Oncol; 2024 May; 25(5):636-648. PubMed ID: 38621404
[TBL] [Abstract][Full Text] [Related]
6. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
7. Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study.
Turtle L; Thorpe M; Drake TM; Swets M; Palmieri C; Russell CD; Ho A; Aston S; Wootton DG; Richter A; de Silva TI; Hardwick HE; Leeming G; Law A; Openshaw PJM; Harrison EM; ; Baillie JK; Semple MG; Docherty AB
PLoS Med; 2023 Jan; 20(1):e1004086. PubMed ID: 36719907
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.
Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS
JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.
Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon KS; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg MJ; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
JAMA Netw Open; 2022 Jun; 5(6):e2215934. PubMed ID: 35671054
[TBL] [Abstract][Full Text] [Related]
10. Clinical epidemiology of COVID-19 in people of black ethnicity living with HIV in the UK.
Ottaway Z; Campbell L; Cechin LR; Patel N; Fox J; Burns F; Hamzah L; Kegg S; Rosenvinge M; Schoeman S; Price D; Jones R; Clarke A; Maan I; Ustianowski A; Onyango D; Tariq S; Miller RF; Post FA;
HIV Med; 2024 May; 25(5):614-621. PubMed ID: 38213094
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
12. Remdesivir for the treatment of COVID-19.
Grundeis F; Ansems K; Dahms K; Thieme V; Metzendorf MI; Skoetz N; Benstoem C; Mikolajewska A; Griesel M; Fichtner F; Stegemann M
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014962. PubMed ID: 36695483
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.
Bennett TD; Moffitt RA; Hajagos JG; Amor B; Anand A; Bissell MM; Bradwell KR; Bremer C; Byrd JB; Denham A; DeWitt PE; Gabriel D; Garibaldi BT; Girvin AT; Guinney J; Hill EL; Hong SS; Jimenez H; Kavuluru R; Kostka K; Lehmann HP; Levitt E; Mallipattu SK; Manna A; McMurry JA; Morris M; Muschelli J; Neumann AJ; Palchuk MB; Pfaff ER; Qian Z; Qureshi N; Russell S; Spratt H; Walden A; Williams AE; Wooldridge JT; Yoo YJ; Zhang XT; Zhu RL; Austin CP; Saltz JH; Gersing KR; Haendel MA; Chute CG;
JAMA Netw Open; 2021 Jul; 4(7):e2116901. PubMed ID: 34255046
[TBL] [Abstract][Full Text] [Related]
15. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.
Nomah DK; Reyes-Urueña J; Díaz Y; Moreno S; Aceiton J; Bruguera A; Vivanco-Hidalgo RM; Llibre JM; Domingo P; Falcó V; Imaz A; Cortés C; Force L; Letang E; Vilaró I; Casabona J; Miro JM;
Lancet HIV; 2021 Nov; 8(11):e701-e710. PubMed ID: 34655549
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
Drake TM; Riad AM; Fairfield CJ; Egan C; Knight SR; Pius R; Hardwick HE; Norman L; Shaw CA; McLean KA; Thompson AAR; Ho A; Swann OV; Sullivan M; Soares F; Holden KA; Merson L; Plotkin D; Sigfrid L; de Silva TI; Girvan M; Jackson C; Russell CD; Dunning J; Solomon T; Carson G; Olliaro P; Nguyen-Van-Tam JS; Turtle L; Docherty AB; Openshaw PJ; Baillie JK; Harrison EM; Semple MG;
Lancet; 2021 Jul; 398(10296):223-237. PubMed ID: 34274064
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State.
Tesoriero JM; Swain CE; Pierce JL; Zamboni L; Wu M; Holtgrave DR; Gonzalez CJ; Udo T; Morne JE; Hart-Malloy R; Rajulu DT; Leung SJ; Rosenberg ES
JAMA Netw Open; 2021 Feb; 4(2):e2037069. PubMed ID: 33533933
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US.
Lang R; Humes E; Coburn SB; Horberg MA; Fathi LF; Watson E; Jefferson CR; Park LS; Gordon KS; Akgün KM; Justice AC; Napravnik S; Edwards JK; Browne LE; Agil DM; Silverberg MJ; Skarbinski J; Leyden WA; Stewart C; Hogan BC; Gebo KA; Marconi VC; Williams CF; Althoff KN;
JAMA Netw Open; 2022 Oct; 5(10):e2236397. PubMed ID: 36227594
[TBL] [Abstract][Full Text] [Related]
19. Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019.
Dandachi D; Geiger G; Montgomery MW; Karmen-Tuohy S; Golzy M; Antar AAR; Llibre JM; Camazine M; Díaz-De Santiago A; Carlucci PM; Zacharioudakis IM; Rahimian J; Wanjalla CN; Slim J; Arinze F; Kratz AMP; Jones JL; Patel SM; Kitchell E; Francis A; Ray M; Koren DE; Baddley JW; Hill B; Sax PE; Chow J
Clin Infect Dis; 2021 Oct; 73(7):e1964-e1972. PubMed ID: 32905581
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.
Spinelli MA; Lynch KL; Yun C; Glidden DV; Peluso MJ; Henrich TJ; Gandhi M; Brown LB
Lancet HIV; 2021 Jun; 8(6):e334-e341. PubMed ID: 33933189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
